LRRK2 and Parkinson disease: Specifically, the fragmented mitochondrial morphology and reduced fluorescence observed in PD cells (including LRRK2+/+ cells), via rhodamine 123 staining, suggested problems with mitochondrial fission/fusion and in maintaining optimal mitochondrial membrane potential.